
|Videos|September 5, 2015
Potential Barriers to Inhaled Insulin
Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses potential barriers to inhaled insulin, like Afrezza.
Advertisement
Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses potential barriers to inhaled insulin, like Afrezza.
This video was filmed at CHPC 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
2
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
3
Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market
4
FDA Approves Depemokimab as Add-On Maintenance Treatment in Severe Asthma
5












































































































































































































